NEW YORK, Feb 5 - Zyomyx, a Hayward, Calif.-based protein chip company, said Monday that Lawrence Cohen, the company’s chief operating officer, had been promoted to CEO.

The company also named Garrett Roper chief financial officer.

Cohen will replace Yasunori Kaneko, who has been CEO since 1998. Kaneko will stay on as chairman of Zyomyx’s board.

A spokeswoman for Zyomyx said that Kaneko had been working as a part-time CEO and that Cohen’s promotion to CEO reflected the his effectiveness as COO.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.